Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug ...

However, these types of injections do not need to occur at specialized facilities. This could mean getting treatment closer to home. Subcutaneous injections can also be given directly into the ...

For permission requests, please contact NEJM Reprints at [email protected] ...

Subcutaneous Opdivo showed comparable effectiveness, safety and tolerability to IV Opdivo in advanced clear cell renal cell ...

Bristol Myers Squibb's Opdivo has been approved in a subcutaneous injection formulation by the FDA, making treatment easier for patients and potentially adding years to the product's patent life.

Approximately two-thirds of patients responded to teduglutide, which is sold under the brand name Gattex as a treatment for ...

for the treatment of adult patients with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor ...

Argenx’s VYVGART Hytrulo prefilled syringe for self-injection has received FDA approval for the treatment of adult patients with generalized myasthenia gravis.

Subcutaneous injection of the drug was done without assistance by 34 adolescents ... and 57.4% of respondents had exacerbations within 12 months of treatment. In March of the same year, the Russian ...

A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous ... required almost 50% less chair and treatment room time for patients as well ...

Both drugs come as a solution that’s given as a subcutaneous injection. Your doctor will show you or a caregiver how to inject Saxenda or Ozempic at home. You’ll inject either drug under the ...